What is the Current Status of Endostatin in Clinical Use?
As of now, endostatin is not widely used in routine clinical practice. However, it remains an active area of research, with numerous ongoing studies aimed at elucidating its full potential. Some promising results have been observed in preclinical models and early-phase clinical trials, particularly when used in combination with other anti-cancer agents. The future of endostatin in cancer therapy will depend on the outcomes of these studies and the development of more efficient delivery methods.
